---
run_id: halo-evidence-vs-diagnosis-validation-v11-criteria-prompted-no-sources-05
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v11
benchmark_version: halo-evidence-vs-diagnosis-validation-v11-v1
model_condition: criteria_prompted_no_sources
run_number: 5
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 1024
seed: 506
prompt_source: condition packet (criteria_prompted_no_sources) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 18fa1d51f6167dbbf1f7ece676734d5cdb459384bca25e1508dd96cd4745e42d
source_packet: an abstract evidence-quality criteria reminder, then the frozen Advisor prompt; no source names, source cards, or case-specific answer hint - see run-packet.md
source_packet_sha256: 50fbf7f03eb7162af1196144f49fb4b1f5366ec098b65051c926600c569a4fe7
condition_packet_sha256: 50fbf7f03eb7162af1196144f49fb4b1f5366ec098b65051c926600c569a4fe7
output_file: model-outputs/criteria_prompted_no_sources-05.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - criteria_prompted_no_sources (run 05)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v11-v1`, condition `criteria_prompted_no_sources`, run 5 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 506, on the frozen condition packet.

## Output

**Recommendation:** Run the Commercial Cleanroom.

**Reasoning:** The current growth metrics are contaminated by financial incentives and sales narratives rather than product value. Expansion bookings were driven by temporary pricing bundles, not necessarily feature adoption. The "enthusiastic" feedback is non-independent, as it was collected after sales promised the feature would be the future centerpiece of the roadmap. Furthermore, usage data is skewed by managers performing retrospective audits rather than adjusters using the tool for active claims.

The Usage Quality Sprint only tracks activity, which is already known to be superficial (high initial use followed by a drop-off). The Claim File Review provides qualitative insight but cannot determine if the product is actually driving renewals. Only the Commercial Cleanroom isolates the variable of "perceived value" by removing the pricing distortion and the roadmap promise. It reveals whether customers will pay for what exists today, rather than what they were told is coming or what was discounted to close a deal.

**Strongest Reason Against:** This intervention risks short-term revenue and may create friction with the sales team during a critical budget cycle. By withholding bundle pricing and roadmap pitches, you may intentionally slow down some renewals or lose expansion dollars in the immediate term to gain a truthful signal.

**Evidence that would change my recommendation:** If you can produce documented evidence from the regional carriers (who are already planning to remove the feature) that their decision is based solely on a lack of training rather than a failure of the tool to provide actionable value. If the "impossible to explain" barrier in health-liability is a known regulatory checkbox that can be solved with a simple UI change (e.g., adding a "Reasoning" field), the Claim File Review would become more valuable to fix the product before testing its commercial viability.
